VANGUARD PLUS CPV
VANGUARD PLUS CPV
Authorised
- Canine parvovirus, strain NL-35-D, Live
Product identification
Medicine name:
VANGUARD PLUS CPV
Active substance:
- Canine parvovirus, strain NL-35-D, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain NL-35-D, Live7.00/log10 cell culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 130192
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 2/11/2021
How useful was this page?:
